Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Concentration of Credit Risk

Note 6 - Concentration of Credit Risk
9 Months Ended
Sep. 30, 2016
Notes to Financial Statements  
Concentration Risk Disclosure [Text Block]
Milestone Scientific
’s consolidated financial instruments that are exposed to concentrations of credit risk consist primarily of cash, trade accounts receivable, and advances on contracts. Milestone Scientific places its cash and cash equivalents with large financial institutions. At times, such investments may be in excess of the Federal Deposit Insurance Corporation insurance limit. Milestone Scientific has not experienced any losses in such accounts and believes it is not exposed to any significant credit risks.
Milestone Scientific closely monitors the extension of credit to its customers while maintain
ing allowances, if necessary, for potential credit losses. Milestone Scientific evaluates its accounts receivable and establishes an allowance for doubtful accounts, based on a history of past write-offs and collections and current credit conditions. Management has provided a reserve that it believes is sufficient to record accounts receivable at net realizable value as of September 30, 2016 and December 31, 2015, respectively.